Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A bisulfite-free intraocular epinephrine solution.

J W Slack1, H F Edelhauser, M J Helenek

  • 1Department of Ophthalmology, Medical College of Wisconsin, Milwaukee.

American Journal of Ophthalmology
|July 15, 1990
PubMed
Summary

A new preservative-free, sulfite-free epinephrine solution shows reduced corneal toxicity for intraocular use. This formulation offers enhanced safety compared to older sulfite-containing epinephrine solutions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic solutions in cataract surgery.

International journal of pharmaceutical compounding·2013
Same author

Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.

The British journal of ophthalmology·2009
Same author

Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.

Gene therapy·2009
Same author

Ocular surgical pharmacology: corneal endothelial safety and toxicity.

Current opinion in ophthalmology·2003
Same author

The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells.

Investigative ophthalmology & visual science·2001
Same author

Transscleral drug delivery for posterior segment disease.

Advanced drug delivery reviews·2001

Area of Science:

  • Ophthalmology
  • Corneal Physiology
  • Ophthalmic Drug Development

Background:

  • Sulfite-containing epinephrine solutions have been associated with corneal toxicity.
  • Epinephrine is used in intraocular irrigating solutions.

Purpose of the Study:

  • To evaluate the corneal toxicity of a novel preservative-free, sulfite-free epinephrine solution.
  • To compare its safety profile against existing epinephrine formulations.

Main Methods:

  • Paired human corneal endothelial perfusion studies were conducted.
  • In vivo studies involved direct anterior chamber injection in New Zealand white rabbits.

Main Results:

  • The preservative-free, sulfite-free epinephrine solution demonstrated no endothelial toxicity at concentrations up to four times the recommended dilution.

Related Experiment Videos

  • Significantly less corneal edema was observed in rabbit models compared to sulfite-containing solutions.

    • Conclusions:

    • The preservative-free, sulfite-free epinephrine solution offers reduced endothelial toxicity.
    • Low buffer capacity, absence of preservatives, and lack of sulfite contribute to its improved safety margin for intraocular procedures.